AbbVie (Q14662364)

https://money.cnn.com/quote/profile/profile.html?symb=ABBV

logo image

AbbVie logo.svg
559 × 105; 3 KB

0 references

short name

ABBV (English)

0 references

chief executive officer

Richard A. Gonzalez

1 January 2013

end time

1 July 2024

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm

Robert A. Michael

1 July 2024

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm

board member

Richard A. Gonzalez

1 January 2013

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Robert Alpern

1 January 2013

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Roxanne Austin

1 January 2013

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Willie Burnside

1 January 2013

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Tom Freyman

8 May 2020

2 references

http://www.pharmabiz.com/NewsDetails.aspx?aid=124066&sid=2

https://www.sec.gov/Archives/edgar/data/1551152/000110465920058837/tm2018740d2_8k.htm

Brett Hart

6 May 2016

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000104746916011386/a2227878zdef14a.htm#Item1

Melody Meyer

5 May 2017

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm

Proxy Statement

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm#PR3

Becky Roberts

4 May 2018

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm

Proxy Statement

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm#A3

Glenn Tilton

1 January 2013

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Rick Waddell

29 November 2012

2 references

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Robert A. Michael

1 July 2024

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm

Jennifer L. Davis

11 October 2023

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm

Susan Quaggin

11 October 2023

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm

Edward J. Rapp

1 January 2013

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

country

United States of America

1 reference

GRID ID

grid.431072.3

retrieved

22 June 2020

https://www.grid.ac/institutes/grid.431072.3

European Federation of Pharmaceutical Industries and Associations

GRID

member of

1 reference

https://www.efpia.eu/about-us/membership/

7 April 2021

0 references

1 reference

17 September 2024

33,266,000,000 United States dollar

2019

1 reference

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm

45,804,000,000 United States dollar

2020

1 reference

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm

56,197,000,000 United States dollar

2021

1 reference

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm

17,444,000,000 United States dollar

2011

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000104746914001154/a2217723z10-k.htm

21 February 2014

18,380,000,000 United States dollar

2012

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000104746915000995/a2223058z10-k.htm

20 February 2015

18,790,000,000 United States dollar

2013

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000104746916010239/a2227341z10-k.htm

19 February 2016

19,960,000,000 United States dollar

2014

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115217000004/abbv-12312016x10k.htm

17 February 2017

22,859,000,000 United States dollar

2015

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115218000014/abbv-20171231x10k.htm

16 February 2018

25,638,000,000 United States dollar

2016

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115219000008/abbv-20181231x10k.htm

27 February 2019

28,216,000,000 United States dollar

2017

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115220000007/abbv-20191231x10k.htm

21 February 2020

32,753,000,000 United States dollar

2018

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115221000008/abbv-20201231.htm

19 February 2021

58,054,000,000 United States dollar

2022

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

1,774,000,000 United States dollar

2014

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115217000004/abbv-12312016x10k.htm

17 February 2017

5,144,000,000 United States dollar

2015

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115218000014/abbv-20171231x10k.htm

16 February 2018

5,953,000,000 United States dollar

2016

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115219000008/abbv-20181231x10k.htm

27 February 2019

5,309,000,000 United States dollar

2017

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115220000007/abbv-20191231x10k.htm

21 February 2020

5,687,000,000 United States dollar

2018

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115221000008/abbv-20201231.htm

19 February 2021

7,882,000,000 United States dollar

2019

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115222000007/abbv-20211231.htm

18 February 2022

4,616,000,000 United States dollar

2020

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

11,542,000,000 United States dollar

2021

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

11,836,000,000 United States dollar

2022

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

3,620,000,000 United States dollar

2011

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000104746914001154/a2217723z10-k.htm

21 February 2014

5,817,000,000 United States dollar

2012

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000104746915000995/a2223058z10-k.htm

20 February 2015

5,664,000,000 United States dollar

2013

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000104746916010239/a2227341z10-k.htm

19 February 2016

3,411,000,000 United States dollar

2014

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115217000004/abbv-12312016x10k.htm

17 February 2017

7,537,000,000 United States dollar

2015

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115218000014/abbv-20171231x10k.htm

16 February 2018

9,340,000,000 United States dollar

2016

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115219000008/abbv-20181231x10k.htm

27 February 2019

9,545,000,000 United States dollar

2017

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115220000007/abbv-20191231x10k.htm

21 February 2020

6,383,000,000 United States dollar

2018

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115221000008/abbv-20201231.htm

19 February 2021

12,983,000,000 United States dollar

2019

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115222000007/abbv-20211231.htm

18 February 2022

11,363,000,000 United States dollar

2020

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

17,924,000,000 United States dollar

2021

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

18,117,000,000 United States dollar

2022

1 reference

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

17 February 2023

location of formation

Delaware

1 reference

Legal Entity Identifier

17 March 2020

0 references

0 references

0 references

0 references

0 references

0 references

headquarters location

North Chicago

0 references

stock exchange

New York Stock Exchange

ticker symbol

ABBV

2 January 2013

2 references

https://en.wikipedia.org/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange

English Wikipedia

Wikimedia import URL

retrieved

21 February 2023

product or material produced or sold, or service provided

medication

1 reference

https://en.wikipedia.org/w/index.php?title=AbbVie_Inc.&oldid=939174101

English Wikipedia

Wikimedia import URL

medical treatment

0 references

official website

http://www.abbvie.com

language of work or name

English

1 reference

1 January 2013

1 reference

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

social media followers

68,170

X numeric user ID

531892451

2 January 2021

0 references

74,470

X numeric user ID

531892451

28 February 2022

0 references

78,227

X numeric user ID

531892451

https://news.abbvie.com/presskits.cfm

6 February 2023

0 references

press information URL

language of work or name

English

1 reference

https://news.abbvie.com/presskits.cfm

title

Press Kits | AbbVie News Center (English)

retrieved

22 January 2023

Commons category

AbbVie Inc.

0 references

Identifiers

Legal Entity Identifier

FR5LCKFTG8054YNNRU85

0 references

ISIN

US00287Y1091

1 reference

German Wikipedia

ISO 9362 SWIFT/BIC code

ABBVUS44XXX

1 reference

https://www.gleif.org/content/4-lei-data/8-lei-mapping/1-download-bic-to-lei-relationship-files/bic_lei_gleif_v1_monthly_full_20200327.csv

27 March 2020

VIAF ID

1457155191921682440005

1 reference

Integrated Authority File

12 October 2022

1 reference

GRID Release 2017-01-10

GND ID

1179216946

1 reference

Virtual International Authority File

VIAF ID

1457155191921682440005

12 October 2022

1 reference

https://en.wikipedia.org/w/index.php?title=List_of_S%26P_500_companies&oldid=986445016

Crunchbase organization ID

English Wikipedia

Corporate Number (Japan)

8010003017396

0 references

abbvie

0 references

EU Transparency Register ID

934069612666-51

1 reference

EU Transparency Register ID

EU Transparency Register

1 August 2023

0 references

0 references

Abbvie-formerly-a-division-of-abbott-pharmaceuticals

0 references

1 reference

10 September 2022

https://golden.com/wiki/AbbVie_Inc.-5EAJB8

Google Scholar organization ID

12853406975335582193

0 references

Great Russian Encyclopedia portal ID

abbvie-e4d6bf

0 references

GRID ID

grid.431072.3

2 references

GRID Release 2015-12-14

verified account or profile

GRID Release 2016-12-06

Instagram username

abbvie

has characteristic

subject named as

AbbVie

0 references

LinkedIn company or organization ID

abbvie

0 references

Open Funder Registry funder ID

100006483

1 reference

Aligned ISNI and Ringgold identifiers for institutions

GRID Release 2017-01-10

0 references

1 reference

0 references

verified account or profile

29 February 2020

number of viewers/listeners

21 March 2012

0 references

YouTube channel ID

UC023GwYXeUQQ6TYHlCaxjOA

subject named as

AbbVie France

number of subscribers

552

number of works

47

141,254

2 February 2016